CRP and cancer: Currently, levels above 10 mg/mL are considered indicative of acute inflammation, and levels above 25 mg/mL are excluded from analysis as too extreme.34 However, this exclusionary approach may not be ideal for a population of cancer survivors and may limit the full elucidation of the CRP response pathway.